Evidence map›Paper›PMID 37926542›Full record

ReviewInternal medicine (Tokyo, Japan)2024

A Significant Increase in the Serum Carbohydrate Antigen 19-9 Level Accompanied by Acute Cholecystitis and Choledocholithiasis: A Case Report and Review of the Literature.

Toshihiro Kawaguchi, Yuya Araki, Akira Kajiwara, Koji Nakao, Shigenari Sakakibara, Yu Sasaki, Hajime Aino, Ryuichiro Maekawa, Yoshinobu Okabe, Takumi Kawaguchi

Abstract readCase ReportsReview
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Toshihiro KawaguchiSocial Insurance Tagawa Hospital, Japan.
Yuya ArakiSocial Insurance Tagawa Hospital, Japan.
Akira KajiwaraSocial Insurance Tagawa Hospital, Japan.
Koji NakaoSocial Insurance Tagawa Hospital, Japan.
Shigenari SakakibaraSocial Insurance Tagawa Hospital, Japan.
Yu SasakiDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan.
Hajime AinoSocial Insurance Tagawa Hospital, Japan.
Ryuichiro MaekawaSocial Insurance Tagawa Hospital, Japan.
Yoshinobu OkabeDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan.
Takumi KawaguchiDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An 80-year-old man with jaundice and fatigue was referred to our hospital. A laboratory examination revealed increased levels of hepatobiliary enzymes, and CA19-9 levels increased to 29,512 U/mL. Based on the findings of imaging examination and laboratory data, the patient was diagnosed with acute cholecystitis and choledocholithiasis. The possibility of malignancy could not be ruled out because of the high levels of CA19-9. Antibiotic administration was commenced, and the common bile duct stone was endoscopically removed. One month after treatment, the CA19-9 level decreased to within the normal range. One year after treatment, imaging examinations did not reveal any malignancy.

Indexed as

CA-19-9 AntigenCholecystitis, AcuteCholedocholithiasisAged, 80 and overHumansMaleCA-19-9 AntigenCA19-9carbohydrate antigen 19-9cholecystitischoledocholithiasisgallstone

Identifiers

PMID37926542
PMCPMC11239259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.